1887

Microbial Genomics logo

Volume 10, Issue 1

Genomic and clinical characteristics of campylobacteriosis in Australia Open Access

Abstract

spp. are a common cause of bacterial gastroenteritis in Australia, primarily acquired from contaminated meat. We investigated the relationship between genomic virulence characteristics and the severity of campylobacteriosis, hospitalisation, and other host factors.

We recruited 571 campylobacteriosis cases from three Australian states and territories (2018–2019). We collected demographic, health status, risk factors, and self-reported disease data. We whole genome sequenced 422 . and 84 . case isolates along with 616 retail meat isolates. We classified case illness severity using a modified Vesikari scoring system, performed phylogenomic analysis, and explored risk factors for hospitalisation and illness severity.

On average, cases experienced a 7.5 day diarrhoeal illness with additional symptoms including stomach cramps (87.1 %), fever (75.6 %), and nausea (72.0 %). Cases aged ≥75 years had milder symptoms, lower Vesikari scores, and higher odds of hospitalisation compared to younger cases. Chronic gastrointestinal illnesses also increased odds of hospitalisation. We observed significant diversity among isolates, with 65 . and 21 . sequence types. Antimicrobial resistance genes were detected in 20.4 % of isolates, but multidrug resistance was rare (0.04 %). Key virulence genes such as () and were prevalent (>90 % presence) but did not correlate with disease severity or hospitalisation. However, certain genes (e.g. , , and ) appeared to distinguish human cases from food source isolates.

Campylobacteriosis generally presents similarly across cases, though some are more severe. Genotypic virulence factors identified in the literature to-date do not predict disease severity but may differentiate human cases from food source isolates. Host factors like age and comorbidities have a greater influence on health outcomes than virulence factors.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): antimicrobial resistance , Campylobacter , clinical outcomes , severity , virulence and whole genome sequencing
Funding
This study was supported by the:
  • Australian Government Research Training Program scholarship (Award N/A)
    • Principle Award Recipient: DanielleM Cribb
  • ACT Health (Award N/A)
    • Principle Award Recipient: NotApplicable
  • Queensland Health (Award N/A)
    • Principle Award Recipient: NotApplicable
  • New South Wales Food Authority (Award N/A)
    • Principle Award Recipient: NotApplicable
  • Food Standards Australia New Zealand (Award N/A)
  • Department of Health and Aged Care, Australian Government (Award N/A)
    • Principle Award Recipient: NotApplicable
  • Agrifutures Australia (Award N/A)
    • Principle Award Recipient: NotApplicable
  • National Health and Medical Research Council (Award GNT1116294)
    • Principle Award Recipient: NotApplicable
© 2024 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.001174
2024-01-12
2024-05-07
Loading full text...

Full text loading...

/deliver/fulltext/mgen/10/1/mgen001174.html?itemId=/content/journal/mgen/10.1099/mgen.0.001174&mimeType=html&fmt=ahah

References

  1. Kaakoush NO, Castaño-Rodríguez N, Mitchell HM, Man SM. Global epidemiology of Campylobacter infection. Clin Microbiol Rev 2015; 28:687–720 [View Article] [PubMed]
     [Google Scholar]
  2. Australian Government Department of Health and Aged Care National Notifiable Disease Surveillance System - National Communicable Disease Surveillance Dashboard; 2023 https://nindss.health.gov.au/pbi-dashboard/
  3. European Centre for Disease Prevention and Control The European union one health 2019 zoonoses report. EFSA J 2021; 19:e06406 [View Article] [PubMed]
     [Google Scholar]
  4. Centers for Disease Control and Prevention FoodNet Fast - Pathogen Surveillance 2022. n.d https://cdc.gov/foodnetfast/
  5. Varrone L, Glass K, Stafford RJ, Kirk MD, Selvey L et al. A meta-analysis of case-control studies examining sporadic campylobacteriosis in Australia and New Zealand from 1990 to 2016. Aust N Z J Public Health 2020; 44:313–319 [View Article] [PubMed]
     [Google Scholar]
  6. Cribb DM, Varrone L, Wallace RL, McLure AT, Smith JJ et al. Risk factors for campylobacteriosis in Australia: outcomes of a 2018-2019 case-control study. BMC Infect Dis 2022; 22:586 [View Article] [PubMed]
     [Google Scholar]
  7. Acheson D, Allos BM. Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis 2001; 32:1201–1206 [View Article]
     [Google Scholar]
  8. Wysok B, Wojtacka J, Hänninen M-L, Kivistö R. Antimicrobial resistance and virulence-associated markers in Campylobacter strains from diarrheic and non-diarrheic humans in Poland. Front Microbiol 2020; 11:1799 [View Article] [PubMed]
     [Google Scholar]
  9. Wieczorek K, Osek J. Antimicrobial resistance mechanisms among Campylobacter. Biomed Res Int 2013; 2013:340605 [View Article] [PubMed]
     [Google Scholar]
  10. Elnegaard S, Andersen RS, Pedersen AF, Larsen PV, Søndergaard J et al. Self-reported symptoms and healthcare seeking in the general population--exploring “The Symptom Iceberg.”. BMC Public Health 2015; 15:685 [View Article] [PubMed]
     [Google Scholar]
  11. McAteer A, Elliott AM, Hannaford PC. Ascertaining the size of the symptom iceberg in a UK-wide community-based survey. Br J Gen Pract 2011; 61:e1–e11 [View Article] [PubMed]
     [Google Scholar]
  12. Gillespie IA, O’Brien SJ, Frost JA, Tam C, Tompkins D et al. Investigating vomiting and/or bloody diarrhoea in Campylobacter jejuni infection. J Med Microbiol 2006; 55:741–746 [View Article] [PubMed]
     [Google Scholar]
  13. Hall G, Kirk M, Ashbolt R, Gregory J, Lalor K et al. Results from the National Gastroenteritis survey 2001 - 2002. In National Centre for Epidemiology and Population Health The Australian National University; 2004
     [Google Scholar]
  14. Wallace RL, Cribb DM, Bulach DM, Ingle DJ, Joensen KG et al. Campylobacter jejuni ST50, a pathogen of global importance: a comparative genomic analysis of isolates from Australia, Europe and North America. Zoonoses Public Health 2021; 68:638–649 [View Article] [PubMed]
     [Google Scholar]
  15. Djeghout B, Bloomfield SJ, Rudder S, Elumogo N, Mather AE et al. Comparative genomics of Campylobacter jejuni from clinical campylobacteriosis stool specimens. Gut Pathog 2022; 14:45 [View Article] [PubMed]
     [Google Scholar]
  16. Dasti JI, Tareen AM, Lugert R, Zautner AE, Gross U. Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Int J Med Microbiol 2010; 300:205–211 [View Article] [PubMed]
     [Google Scholar]
  17. de Oliveira MG, Rizzi C, Galli V, Lopes GV, Haubert L et al. Presence of genes associated with adhesion, invasion, and toxin production in Campylobacter jejuni isolates and effect of temperature on their expression. Can J Microbiol 2019; 65:253–260 [View Article] [PubMed]
     [Google Scholar]
  18. Silva J, Leite D, Fernandes M, Mena C, Gibbs PA et al. Campylobacter spp. as a foodborne pathogen: a review. Front Microbiol 2011; 2:200 [View Article] [PubMed]
     [Google Scholar]
  19. Ramires T, de Oliveira MG, Kleinubing NR, de Fátima Rauber Würfel S, Mata MM et al. Genetic diversity, antimicrobial resistance, and virulence genes of thermophilic Campylobacter isolated from broiler production chain. Braz J Microbiol 2020; 51:2021–2032 [View Article] [PubMed]
     [Google Scholar]
  20. Bolton DJ. Campylobacter virulence and survival factors. Food Microbiol 2015; 48:99–108 [View Article] [PubMed]
     [Google Scholar]
  21. Varrone L, Stafford RJ, Lilly K, Selvey L, Glass K et al. Investigating locally relevant risk factors for Campylobacter infection in Australia: protocol for a case-control study and genomic analysis. BMJ Open 2018; 8:e026630 [View Article] [PubMed]
     [Google Scholar]
  22. Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 1990; 22:259–267 [View Article] [PubMed]
     [Google Scholar]
  23. Schnadower D, Tarr PI, Gorelick MH, O’Connell K, Roskind CG et al. Validation of the modified Vesikari score in children with gastroenteritis in 5 US emergency departments. J Pediatr Gastroenterol Nutr 2013; 57:514–519 [View Article] [PubMed]
     [Google Scholar]
  24. Shim DH, Kim DY, Cho KY. Diagnostic value of the Vesikari scoring system for predicting the viral or bacterial pathogens in pediatric gastroenteritis. Korean J Pediatr 2016; 59:126–131 [View Article] [PubMed]
     [Google Scholar]
  25. Hall G, Yohannes K, Raupach J, Becker N, Kirk M. Estimating community incidence of Salmonella, Campylobacter, and Shiga toxin-producing Escherichia coli infections, Australia. Emerg Infect Dis 2008; 14:1601–1609 [View Article] [PubMed]
     [Google Scholar]
  26. Walker LJ, Wallace RL, Smith JJ, Graham T, Saputra T et al. Prevalence of Campylobacter coli and Campylobacter jejuni in retail chicken, beef, lamb, and pork products in three Australian states. J Food Prot 2019; 82:2126–2134 [View Article] [PubMed]
     [Google Scholar]
  27. Wallace RL, Bulach DM, Jennison AV, Valcanis M, McLure A et al. Molecular characterization of Campylobacter spp. recovered from beef, chicken, lamb and pork products at retail in Australia. PLoS One 2020; 15:e0236889 [View Article] [PubMed]
     [Google Scholar]
  28. Klena JD, Parker CT, Knibb K, Ibbitt JC, Devane PML et al. Differentiation of Campylobacter coli, Campylobacter jejuni, Campylobacter lari, and Campylobacter upsaliensis by a multiplex PCR developed from the nucleotide sequence of the lipid a gene lpxA. J Clin Microbiol 2004; 42:5549–5557 [View Article] [PubMed]
     [Google Scholar]
  29. Jolley KA, Bray JE, Maiden MCJ. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res 2018; 3:124 [View Article] [PubMed]
     [Google Scholar]
  30. Liu B, Zheng D, Zhou S, Chen L, Yang J. VFDB 2022: a general classification scheme for bacterial virulence factors. Nucleic Acids Res 2022; 50:D912–D917 [View Article] [PubMed]
     [Google Scholar]
  31. Wallace RL, Bulach D, McLure A, Varrone L, Jennison AV et al. Antimicrobial resistance of Campylobacter spp. Causing human infection in Australia: an international comparison. Microb Drug Resist 2021; 27:518–528 [View Article] [PubMed]
     [Google Scholar]
  32. Zeng X, Brown S, Gillespie B, Lin J. A single nucleotide in the promoter region modulates the expression of the β-lactamase OXA-61 in Campylobacter jejuni. J Antimicrob Chemother 2014; 69:1215–1223 [View Article] [PubMed]
     [Google Scholar]
  33. Ladely SR, Meinersmann RJ, Englen MD, Fedorka-Cray PJ, Harrison MA. 23S rRNA gene mutations contributing to macrolide resistance in Campylobacter jejuni and Campylobacter coli. Foodborne Pathog Dis 2009; 6:91–98 [View Article] [PubMed]
     [Google Scholar]
  34. Hakanen A, Jalava J, Kotilainen P, Jousimies-Somer H, Siitonen A et al. gyrA polymorphism in Campylobacter jejuni: detection of gyrA mutations in 162 C. jejuni isolates by single-strand conformation polymorphism and DNA sequencing. Antimicrob Agents Chemother 2002; 46:2644–2647 [View Article] [PubMed]
     [Google Scholar]
  35. Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes. Drug Resist Updat 2010; 13:151–171 [View Article] [PubMed]
     [Google Scholar]
  36. Whitehouse CA, Young S, Li C, Hsu C-H, Martin G et al. Use of whole-genome sequencing for Campylobacter surveillance from NARMS retail poultry in the United States in 2015. Food Microbiol 2018; 73:122–128 [View Article] [PubMed]
     [Google Scholar]
  37. Qin S, Wang Y, Zhang Q, Zhang M, Deng F et al. Report of ribosomal RNA methylase gene erm(B) in multidrug-resistant Campylobacter coli. J Antimicrob Chemother 2014; 69:964–968 [View Article] [PubMed]
     [Google Scholar]
  38. Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268–281 [View Article] [PubMed]
     [Google Scholar]
  39. Wieczorek K, Wołkowicz T, Osek J. Antimicrobial resistance and virulence-associated traits of Campylobacter jejuni isolated from poultry food chain and humans With diarrhea. Front Microbiol 2018; 9:1508 [View Article] [PubMed]
     [Google Scholar]
  40. Quino W, Caro-Castro J, Hurtado V, Flores-León D, Gonzalez-Escalona N et al. Genomic analysis and antimicrobial resistance of Campylobacter jejuni and Campylobacter coli in Peru. Front Microbiol 2022; 12: [View Article]
     [Google Scholar]
  41. Bravo V, Katz A, Porte L, Weitzel T, Varela C et al. Genomic analysis of the diversity, antimicrobial resistance and virulence potential of clinical Campylobacter jejuni and Campylobacter coli strains from Chile. PLoS Negl Trop Dis 2021; 15:e0009207 [View Article] [PubMed]
     [Google Scholar]
  42. Breinman L, Cutler A, Liaw A, Wiener M. randomForest: Breiman and Cutler’s Random Forests for Classification and Regression; 2022 https://cran.rproject.org/web/packages/randomForest/index.html
  43. Kuhn M, Wing J, Weston S, Williams A, Keefer C et al. caret: Classification and Regression Training; 2023 https://cran.rproject.org/web/packages/caret/
  44. Kooperberg C, Ruczinski I. LogicReg: Logic Regression 2022
     [Google Scholar]
  45. Gibb S, binda SK. Multi-Class Discriminant Analysis using Binary Predictors; 2021 https://cran.r-project.org/web/packages/binda/index.html
  46. R Core Team R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; n.d https://www.R-project.org
  47. Wood S. mgcv: Mixed GAM Computation Vehicle with Automatic Smoothness Estimation; 2023 https://cran.r-project.org/web/packages/mgcv/index.html
  48. Letunic I, Bork P. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res 2021; 49:W293–W296 [View Article] [PubMed]
     [Google Scholar]
  49. Díaz-Regañón D, Gabriel V, Livania V, Liu D, Ahmed BH et al. Changes of enterocyte morphology and enterocyte: goblet cell ratios in dogs with protein-losing and non-protein-losing chronic enteropathies. Vet Sci 2023; 10:417 [View Article] [PubMed]
     [Google Scholar]
  50. Jackson MA, Goodrich JK, Maxan M-E, Freedberg DE, Abrams JA et al. Proton pump inhibitors alter the composition of the gut microbiota. Gut 2016; 65:749–756 [View Article] [PubMed]
     [Google Scholar]
  51. Chen Y, Liu B, Glass K, Du W, Banks E et al. Use of proton pump inhibitors and the risk of hospitalization for infectious gastroenteritis. PLoS One 2016; 11:e0168618 [View Article] [PubMed]
     [Google Scholar]
  52. Marsden GL, Li J, Everest PH, Lawson AJ, Ketley JM. Creation of a large deletion mutant of Campylobacter jejuni reveals that the Lipooligosaccharide gene cluster is not required for viability. J Bacteriol 2009; 191:2392–2399 [View Article]
     [Google Scholar]
  53. Moffatt CRM, Kennedy KJ, Selvey L, Kirk MD. Campylobacter-associated hospitalisations in an Australian provincial setting. BMC Infect Dis 2021; 21:10 [View Article] [PubMed]
     [Google Scholar]
  54. White AE, Ciampa N, Chen Y, Kirk M, Nesbitt A et al. Characteristics of Campylobacter and Salmonella infections and acute gastroenteritis in older adults in Australia, Canada, and the United States. Clin Infect Dis 2019; 69:1545–1552 [View Article] [PubMed]
     [Google Scholar]
  55. Quetz J da S, Lima IFN, Havt A, Prata MMG, Cavalcante PA et al. Campylobacter jejuni infection and virulence-associated genes in children with moderate to severe diarrhoea admitted to emergency rooms in northeastern Brazil. J Med Microbiol 2012; 61:507–513 [View Article] [PubMed]
     [Google Scholar]
  56. Kamal N, Dorrell N, Jagannathan A, Turner SM, Constantinidou C et al. Deletion of a previously uncharacterized flagellar-hook-length control gene fliK modulates the sigma54-dependent regulon in Campylobacter jejuni. Microbiology 2007; 153:3099–3111 [View Article] [PubMed]
     [Google Scholar]
  57. Javed MA, Cawthraw SA, Baig A, Li J, McNally A et al. Cj1136 is required for lipooligosaccharide biosynthesis, hyperinvasion, and chick colonization by Campylobacter jejuni. Infect Immun 2012; 80:2361–2370 [View Article] [PubMed]
     [Google Scholar]
  58. Rukambile E, Sintchenko V, Muscatello G, Kock R, Alders R. Infection, colonization and shedding of Campylobacter and Salmonella in animals and their contribution to human disease: a review. Zoonoses Public Health 2019; 66:562–578 [View Article] [PubMed]
     [Google Scholar]
  59. Lopes GV, Ramires T, Kleinubing NR, Scheik LK, Fiorentini ÂM et al. Virulence factors of foodborne pathogen Campylobacter jejuni. Microb Pathog 2021; 161:105265 [View Article] [PubMed]
     [Google Scholar]
  60. Bacon DJ, Szymanski CM, Burr DH, Silver RP, Alm RA et al. A phase-variable capsule is involved in virulence of Campylobacter jejuni 81-176. Mol Microbiol 2001; 40:769–777 [View Article] [PubMed]
     [Google Scholar]
  61. Konkel ME, Monteville MR, Rivera-Amill V, Joens LA. The pathogenesis of Campylobacter jejuni-mediated enteritis. Curr Issues Intest Microbiol 2001; 2:55–71 [PubMed]
     [Google Scholar]
  62. Casabonne C, Gonzalez A, Aquili V, Subils T, Balague C. Prevalence of seven virulence genes of Campylobacter jejuni isolated from patients with diarrhea in rosario, Argentina. Int J Infect 2016; 3:e37727 [View Article]
     [Google Scholar]
  63. Ghunaim H, Behnke JM, Aigha I, Sharma A, Doiphode SH et al. Analysis of resistance to antimicrobials and presence of virulence/stress response genes in Campylobacter isolates from patients with severe diarrhoea. PLoS One 2015; 10:e0119268 [View Article] [PubMed]
     [Google Scholar]
  64. Kreling V, Falcone FH, Kehrenberg C, Hensel A. Campylobacter sp.: pathogenicity factors and prevention methods-new molecular targets for innovative antivirulence drugs?. Appl Microbiol Biotechnol 2020; 104:10409–10436 [View Article] [PubMed]
     [Google Scholar]
  65. Biswas D, Hannon SJ, Townsend HGG, Potter A, Allan BJ. Genes coding for virulence determinants of Campylobacter jejuni in human clinical and cattle isolates from Alberta, Canada, and their potential role in colonization of poultry. Int Microbiol 2011; 14:25–32 [View Article] [PubMed]
     [Google Scholar]
  66. Kim JS, Lee MY, Kim SJ, Jeon S-E, Cha I et al. High-level ciprofloxacin-resistant Campylobacter jejuni isolates circulating in humans and animals in incheon, Republic of Korea. Zoonoses Public Health 2016; 63:545–554 [View Article] [PubMed]
     [Google Scholar]
  67. Whitehouse CA, Balbo PB, Pesci EC, Cottle DL, Mirabito PM et al. Campylobacter jejuni cytolethal distending toxin causes a G2-phase cell cycle block. Infect Immun 1998; 66:1934–1940 [View Article] [PubMed]
     [Google Scholar]
  68. Hickey TE, McVeigh AL, Scott DA, Michielutti RE, Bixby A et al. Campylobacter jejuni cytolethal distending toxin mediates release of interleukin-8 from intestinal epithelial cells. Infect Immun 2000; 68:6535–6541 [View Article] [PubMed]
     [Google Scholar]
  69. Asakura M, Samosornsuk W, Hinenoya A, Misawa N, Nishimura K et al. Development of a cytolethal distending toxin (cdt) gene-based species-specific multiplex PCR assay for the detection and identification of Campylobacter jejuni, Campylobacter coli and Campylobacter fetus. FEMS Immunol Med Microbiol 2008; 52:260–266 [View Article] [PubMed]
     [Google Scholar]
  70. Park SF. The physiology of Campylobacter species and its relevance to their role as foodborne pathogens. Int J Food Microbiol 2002; 74:177–188 [View Article] [PubMed]
     [Google Scholar]
  71. Lapierre L, Gatica MA, Riquelme V, Vergara C, Yañez JM et al. Characterization of antimicrobial susceptibility and its association with virulence genes related to adherence, invasion, and cytotoxicity in Campylobacter jejuni and Campylobacter coli isolates from animals, meat, and humans. Microb Drug Resist 2016; 22:432–444 [View Article] [PubMed]
     [Google Scholar]
  72. Hansson I, Sandberg M, Habib I, Lowman R, Engvall EO. Knowledge gaps in control of Campylobacter for prevention of campylobacteriosis. Transbound Emerg Dis 2018; 65:30–48 [View Article] [PubMed]
     [Google Scholar]
  73. Godschalk PCR, Kuijf ML, Li J, St Michael F, Ang CW et al. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and miller fisher syndromes. Infect Immun 2007; 75:1245–1254 [View Article] [PubMed]
     [Google Scholar]
  74. Therapeutic Guidelines Limited Acute infectious diarrhoea; 2022 https://tgldcdp.tg.org.au/viewTopic?etgAccess=true&guidelinePage=Antibiotic&topicfile=acute-gastroenteritis&guidelinename=Antibiotic§ionId=toc_d1e521#toc_d1e521 accessed 26 June 2023
  75. Cheng AC, Turnidge J, Collignon P, Looke D, Barton M et al. Control of fluoroquinolone resistance through successful regulation, Australia. Emerg Infect Dis 2012; 18:1453–1460 [View Article] [PubMed]
     [Google Scholar]
  76. Andrzejewska M, Grudlewska-Buda K, Śpica D, Skowron K, Ćwiklińska-Jurkowska M et al. Genetic relatedness, virulence, and drug susceptibility of Campylobacter isolated from water and wild birds. Front Cell Infect Microbiol 2022; 12:1005085 [View Article] [PubMed]
     [Google Scholar]
  77. Wysok B, Wojtacka J, Kivistö R. Pathogenicity of Campylobacter strains of poultry and human origin from Poland. Int J Food Microbiol 2020; 334:108830 [View Article] [PubMed]
     [Google Scholar]
  78. González-Hein G, Huaracán B, García P, Figueroa G. Prevalence of virulence genes in strains of Campylobacter jejuni isolated from human, bovine and broiler. Braz J Microbiol 2013; 44:1223–1229 [View Article] [PubMed]
     [Google Scholar]
  79. Lluque A, Riveros M, Prada A, Ochoa TJ, Ruiz J. Virulence and antimicrobial resistance in Campylobacter spp. from a peruvian pediatric cohort. Scientifica 2017; 2017:7848926 [View Article] [PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/mgen/10.1099/mgen.0.001174
Loading
Genomic and clinical characteristics of campylobacteriosis in Australia
M Gen 10, 001174 (2024); https://doi.org/10.1099/mgen.0.001174
/content/journal/mgen/10.1099/mgen.0.001174
/content/journal/mgen/10.1099/mgen.0.001174
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error